The Korea Herald

Print edition

Stämm's Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots

Latest News

South Korea's WIRobotics Takes the Spotlight at CES 2025, Plans Global Expansion

YONGIN, South Korea, Jan. 15, 2025 /PRNewswire/ -- WIRobotics, the company behind the revolutionary wearable mobility solution WIM(We Innovate Mobility), has achieved a major milestone at CES 2025, one of the world's premier technology trade shows. Featuring more than 4,500 companies from 166 countries showcasing cutting-edge innovations, the event set a new record this year, with WIRobotics emerging as one of its standout success stories. At CES, held January 7–10 in Las Vegas, WIM, the company
Jan. 15, 2025
BRI Distributes Rp20.33 Trillion Interim Dividend, Driving Value for Shareholders and State

JAKARTA, Indonesia, Jan. 15, 2025 /PRNewswire/ -- PT Bank Rakyat Indonesia (Persero) Tbk. (IDX: BBRI) is pleased to announce it will distribute Rp135 per share of interim dividends, totaling Rp20.33 trillion. The distribution takes place on Wednesday, January 15, 2025, and demonstrates BRI's commitment to generating shareholder value. BRI President Director Sunarso explained that this decision to distribute dividends shows the company's dedication to providing sustainable profits for shareholder
Jan. 15, 2025
USPS Unveils Latest Lunar New Year Stamp

2025 is the Year of the Snake BOSTON, Jan. 15, 2025 /PRNewswire/ -- Today, the U.S. Postal Service unveiled the Lunar New Year: Year of the Snake stamp in the historic Boch Center Wang Theatre in Boston. The Postal Service printed 21 million stamps that are now on sale at Post Offices and usps.com. Share the news on social media using the hashtags #LunarNewYearSnake and #LunarNewYearStamp. "Our Lunar New Year stamp series is extremely popular and we are very proud of how it highlights and celebr
Jan. 15, 2025
APPOINTMENT OF ARVIND BHANDARI AS CHAIRMAN AND MANAGING DIRECTOR OF GOODYEAR INDIA

SHANGHAI, Jan. 15, 2025 /PRNewswire/ -- Goodyear is pleased to announce the appointment of Arvind Bhandari as Chairman and Managing Director of Goodyear India, effective January 2, 2025. Based in Delhi, Mr. Bhandari will oversee the company's India business operations, driving strategic initiatives to strengthen Goodyear's market position and deliver sustainable growth. Mr. Bhandari is a seasoned business leader with extensive experience spanning sales, marketing, and general management roles ac
Jan. 15, 2025
FOURTH FUTURE MINERALS FORUM 2025 KICKS OFF WITH 90 COUNTRIES AND 16 G20 NATIONS AT MINISTERIAL ROUNDTABLE

RIYADH, Saudi Arabia, Jan. 14, 2025 /PRNewswire/ -- The Fourth Ministerial Roundtable meeting began today as part of the Future Minerals Forum, hosting government representatives from 90 countries, including 16 G20 nations. The event featured participation from 50 international organizations, NGOs and global leaders in the mining industry. This government-led meeting seeks to bolster international collaboration in producing the critical minerals essential for the energy transition. It provides a
Jan. 14, 2025
Next Level Aviation® Commences Recap of Turning Rock Partners

NLA to complete the full redemption of Turning Rock's preferred equity investment by June 30, 2025 DANIA BEACH, Fla., Jan. 14, 2025 /PRNewswire/ -- Next Level Aviation® (NLA), a leader in the global distribution of used serviceable materials (USM) for all Boeing and Airbus commercial aircraft and associated jet engine platforms, has agreed to redeem Turning Rock Partners' (TRP) 2019 preferred equity investment. NLA made the first significant payment of the redemption agreement to TRP just prior
Jan. 14, 2025
Cognex Strengthens Market Leadership in Industrial Barcode Reading with Two New AI-Powered Products

DataMan 290 and 390 barcode readers, backed by industry-leading customer support, deliver unmatched reliability and ease of use NATICK, Mass., Jan. 14, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the leader in industrial machine vision, today announced the launch of the DataMan® 290 and 390 barcode readers. Thanks to innovative AI technology, these readers deliver reliable decoding performance across a broad range of manufacturing applications. In addition, by making setup and deploy
Jan. 14, 2025
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility

Powered by Android 14 and Qualcomm® Snapdragon™ 6490 Octa-Core Processor, Engineered for Demanding Fleet Applications TAIPEI, Jan. 14, 2025 /PRNewswire/ -- RuggON Corporation proudly introduces the VIKING II, a groundbreaking fleet management device designed to tackle the toughest industrial challenges. Combining cutting-edge technology with exceptional durability, the VIKING II raises the bar for operational efficiency in logistics, mining, construction, and public safety. Designed with adapta
Jan. 14, 2025
IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award

Recognized for brand leadership with its "Timing is Everything" controlled release platform for oral drug delivery. NEW YORK, Jan. 14, 2025 /PRNewswire/ -- IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, announced today that it has won the 2024 Pharmaceutical Technology Excellence Awards' Brand Leadership category for its "Timing is Everything" campaign. The campaign features IFF's newly designed controlled release platform, which provides customers with solutions at ev
Jan. 14, 2025
Korea's Leading Indie Beauty Brand d'Alba, Reaches New Heights Globally with 210% Overseas Sales Surge

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ -- Premium vegan beauty brand d'Alba has achieved significant growth in its overseas sales, rising to approximately KRW 150 billion won (USD 100 million) in 2024 - which is a 210% growth compared to the previous year. With this growth, d'Alba's international market revenue now accounts for 45% of its total revenue. Its global growth came from its flagship product, the White Truffle First Spray Serum, alongside Waterful Sunscreen and Double cream. d'
Jan. 14, 2025
ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ -- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for 'Pemziviptadil (development code name PF1804),' a treatment for DMD (Duchenne Muscular Dystrophy) cardiomyopathy, from the U.S. Food and Drug Administration (FDA). Pemziviptadil is a once-weekly DMD cardiomyopathy drug developed based on ImmunForge's long-acting drug platform, the ELP Platform (Elastin Like Polypeptide Platform). Pemziviptadil is a vasoacti
Jan. 14, 2025

1
2
3
4
5
6
7
8
9
10